For the IL-6 marker, higher concentrations were significantly associated with hypertriglyceridemia (Model 1, OR = 1.095, 95% CI: 1.053–1.139, p = 0.000; Model 2, OR = 1.096, 95% CI: 1.044–1.151, p = 0.000) and insulin resistance (HOMA-IR: Model 1, OR = 1.066, 95% CI: 1.028–1.105, p = 0.001; Model 2, OR = 1.058, 95% CI: 1.011–1.107, p = 0.014). Here, IL6 is linked to hypertriglyceridemia.